Видео ютуба по тегу Medicines: Casdatifan

ARC-20: Casdatifan Plus Cabozantinib Expansion Cohort
ARC-20: Casdatifan Plus Cabozantinib Expansion Cohort
ARC-20: casdatifan monotherapy in pre-treated clear cell renal cell carcinoma
ARC-20: casdatifan monotherapy in pre-treated clear cell renal cell carcinoma
ASCOGU25: Toni Choueiri MD., on Casdatifan | Dana-Farber Cancer Institute
ASCOGU25: Toni Choueiri MD., on Casdatifan | Dana-Farber Cancer Institute
ARC-20: Casdatifan for Patients With Previously Treated ccRCC
ARC-20: Casdatifan for Patients With Previously Treated ccRCC
Toni Choueiri on casdatifan in kidney cancer: ENA24 | Dana-Farber Cancer Institute
Toni Choueiri on casdatifan in kidney cancer: ENA24 | Dana-Farber Cancer Institute
New and upcoming treatments for clear cell renal cell carcinoma
New and upcoming treatments for clear cell renal cell carcinoma
2025 ASCO Kidney Cancer Highlights
2025 ASCO Kidney Cancer Highlights
KCRS24 - Biotech Showcase on Emerging Therapies for Kidney Cancer | KidneyCAN
KCRS24 - Biotech Showcase on Emerging Therapies for Kidney Cancer | KidneyCAN
Evaluating the evolving role of belzutifan in renal cell carcinoma
Evaluating the evolving role of belzutifan in renal cell carcinoma
BCG, Biomarkers, and Beyond: GU Oncology Research and Treatment Advances
BCG, Biomarkers, and Beyond: GU Oncology Research and Treatment Advances
Biotech Showcase | Kidney Cancer Research Summit 2025
Biotech Showcase | Kidney Cancer Research Summit 2025
EA8143/PROSPER RCC Clinical Trial for Renal Cell Carcinoma
EA8143/PROSPER RCC Clinical Trial for Renal Cell Carcinoma
FDA D.I.S.C.O. Burst Edition: FDA approvals of Erbitux (cetuximab) for K-Ras wild type, EGFR-expr...
FDA D.I.S.C.O. Burst Edition: FDA approvals of Erbitux (cetuximab) for K-Ras wild type, EGFR-expr...
ASCO25: Toni Choueiri, MD, ARC-20 Study | Dana-Farber Cancer Institute
ASCO25: Toni Choueiri, MD, ARC-20 Study | Dana-Farber Cancer Institute
The Canadian Medstore
The Canadian Medstore
Стандарт клинической помощи при применении психотропных лекарственных средств – краткий обзор
Стандарт клинической помощи при применении психотропных лекарственных средств – краткий обзор
FDA D.I.S.C.O. Burst Edition: FDA approval of Padcev (enfortumab vedotin-ejfv) with Keytruda (pem...
FDA D.I.S.C.O. Burst Edition: FDA approval of Padcev (enfortumab vedotin-ejfv) with Keytruda (pem...
Discover the Latest Genitourinary Cancer Updates
Discover the Latest Genitourinary Cancer Updates
FDA D.I.S.C.O. Burst Edition: FDA approval of Lenvima (lenvatinib) in combination with Keytruda (...
FDA D.I.S.C.O. Burst Edition: FDA approval of Lenvima (lenvatinib) in combination with Keytruda (...
FDA D.I.S.C.O. Burst Edition: FDA approvals of Lumakras (sotorasib) for patients with KRAS G12C ...
FDA D.I.S.C.O. Burst Edition: FDA approvals of Lumakras (sotorasib) for patients with KRAS G12C ...